| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride manufacturers
|
| | 1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride Basic information |
| Product Name: | 1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride | | Synonyms: | GlafenineHCl;Glafenin hydrochloride;GLAFENINE HYDROCHLORIDE;2,3-Dihydroxypropyl 2-((7-chloroquinolin-4-yl)amino)benzoate hydrochloride;inhibit,Glafenine Hydrochloride,Glafenine,Glafenin,Inhibitor;1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride | | CAS: | 65513-72-6 | | MF: | C19H18Cl2N2O4 | | MW: | 409.26 | | EINECS: | | | Product Categories: | | | Mol File: | 65513-72-6.mol | ![1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride Structure](CAS/GIF/65513-72-6.gif) |
| | 1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride Chemical Properties |
| storage temp. | Inert atmosphere,Room Temperature | | solubility | DMSO : ≥ 60 mg/mL (146.61 mM) | | form | Solid | | color | Light yellow to yellow | | Major Application | forensics and toxicology pharmaceutical (small molecule) | | InChI | 1S/C19H17ClN2O4.ClH/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23;/h1-9,13,23-24H,10-11H2,(H,21,22);1H | | InChIKey | CEUMONXVSJOJIH-UHFFFAOYSA-N | | SMILES | Cl.OCC(O)COC(=O)c1ccccc1Nc2ccnc3cc(Cl)ccc23 |
| Hazard Codes | Xn | | Risk Statements | 22 | | Safety Statements | 36 | | WGK Germany | 3 | | RTECS | CB2687000 | | Storage Class | 11 - Combustible Solids |
| | 1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride Usage And Synthesis |
| Uses | Analgesic | | in vivo | Glafenine injection (25 mg/kg i.v.) shows enhanced BLI signal in mice with an average of 2.9-fold signal enhancement over the control. Glafenine causes increases in BLI signal of up to 11.6- and 17.4-fold in two separate HEK293/ABCG2/fLuc xenografts in the same mouse compared to the signals generated by those xenografts immediately before injection[1]. Incubating polarized CFBE41o- monolayers and intestines isolated from mutant CFTR mice with glafenine increases the short-circuit current response to forskolin and genistein. Treatment with glafenine also partially restores total salivary secretion[2]. Glafenine-treated zebrafish shows evidence of endoplasmic reticulum and mitochondrial stress, with disrupted intestinal architecture and halted cell stress responses, alongside accumulation of apoptotic intestinal epithelial cells in the lumen[4]. |
| | 1-Glyceryl N-[7-chloro-4-quinolyl]anthranilate hydrochloride Preparation Products And Raw materials |
|